Dr. Francesco Ruffino is an Associate Professor of Experimental Physics at the University of Catania, Italy. His research is focused on the study and fabrication of metal-based nanostructures, nanomaterials and nanocomposites and on their applications in some important technological fields connected to the challenges of the human society. External content Scientific Reports High optical enhancement... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Nov. 5, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual 2021 Stifel Healthcare Conference on Tuesday, November 16, 2021 at 8:40 a.m. ET. Jamey Mock, senior vice president and chief financial officer of PerkinElmer, will provide... Read more
<!– –> Improvement in patient and medical staff safety in healthcare organizations is one of the core components of high quality care. Healthcare management needs to employ proactive and systematic methods to prevent the risk of patient and medical staff injuries such as patient falls, ergonomic injuries, infection risk, and so on. Shimadzu Medical Systems... Read more
New Paper Outlines Steps to Accelerate Sector’s Progress Toward Zero-Carbon Future RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 4, 2021– Global water utilities account for approximately 2% of greenhouse gas (GHG) emissions – the equivalent of the world’s shipping industry. And this figure is set to spiral as utilities work towards the UN’s Sustainable Development Goal of universal... Read more
Brooks Automation Announces Fiscal 2021 Fourth Quarter and Year-End Earnings Conference Call and Webcast CHELMSFORD, Mass., Nov. 4, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 fourth quarter and year-end earnings which ended on September 30, 2021 on Wednesday, November 10, 2021 after the market closes. The Company will host a conference... Read more
FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021. “Our strong performance in fiscal 2021 was driven by the extraordinary efforts of our global team and demonstrates the resilience... Read more
加州門洛公園和香港, Nov. 04, 2021 (GLOBE NEWSWIRE) — PacBio 將向全球領先的基因組學和診斷測試公司 Prenetics Group Limited 提供高品質、高度準確的測序平台。該公司在香港、東南亞和英國增加了更全面的基因篩查服務，包括攜帶者篩查和癌症風險篩查。 Prenetics 行政總裁 Danny Yeung 表示：「隨著 CircleDNA 在全球為消費者取得成功，Circle Medical 將成為專供醫生專業服務的醫生專用產品。與 PacBio 的合作使我們能夠在消費者和臨床環境中擴大下一代測序技術的實用性和機會。」 Prenetics 臨床總監 Senthil Sundaram 醫學博士表示：「PacBio 的 SMRT HiFi 測序技術能夠在攜帶者篩查和癌症風險篩查中提供額外的基因資訊，我們很高興將這優勢帶給客戶和患者。」 PacBio 的技術將成為 Prenetics 的 Circle Medical 產品的關鍵組成部分，這是一種基因測試，旨在滿足醫生的診斷需求並提高檢測突變的準確性。Prenetics 還利用 PacBio 技術將表觀基因組學應用於終端消費者的產品，例如老齡、護膚和人口健康，以及用於醫療的產品，例如腸癌和肝癌。 PacBio 行政總裁 Christian Henry 表示：「這種合作夥伴關係體現了 PacBio SMRT 測序技術與世界頂級研究人員的創造力結合時的適應能力。Prenetics 已在全球內顯示出強勁的業務增長，我們很高興與他們密切合作，共同推動臨床基因組學的下一階段增長。」 PacBio 科學總監 Jonas Korlach... Read more
Roche and Novartis agree on the repurchase by Roche Holding Ltd of 53.3 million Roche shares from Novartis Holding AG. Repurchase is conditional upon the approval of a capital reduction by cancellation of the repurchased shares and the approval of the interim financial statements prepared for the purpose of the transaction by an Extraordinary General... Read more
MENLO PARK, Calif. and HONG KONG, Nov. 03, 2021 (GLOBE NEWSWIRE) — PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global genomics and diagnostic testing company, as the firm adds more comprehensive genetic screening services including carrier screening and cancer-risk screening in Hong Kong, Southeast Asia and... Read more